成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

GSK-598809 L-tartrate sesquihydrate

CAS No.
1008521-09-2
Chemical Name:
GSK-598809 L-tartrate sesquihydrate
Synonyms
GSK-598809 L-tartrate sesquihydrate;3-Azabicyclo[3.1.0]hexane, 1-[2-fluoro-4-(trifluoromethyl)phenyl]-3-[3-[[4-methyl-5-(4-methyl-5-oxazolyl)-4H-1,2,4-triazol-3-yl]thio]propyl]-, (1S,5R)-, (2R,3R)-2,3-dihydroxybutanedioate, hydrate (2:2:3)
CBNumber:
CB413375678
Molecular Formula:
C22H23F4N5OS.C4H6O6.3/2H2…
Molecular Weight:
1317.24
MDL Number:
MOL File:
Mol file
Last updated:2024-10-28 16:48:35

GSK-598809 L-tartrate sesquihydrate Properties

FDA UNII 015F06XTHY

GSK-598809 L-tartrate sesquihydrate Preparation Products And Raw materials

Raw materials

Preparation Products

GSK-598809 L-tartrate sesquihydrate Suppliers

Global( 2)Suppliers
Supplier Tel Email Country ProdList Advantage
TargetMol Chemicals Inc.
+8613564774135 zijue.cai@tsbiochem.com United States 19881 58
TargetMol Chemicals Inc. 15002134094 marketing@targetmol.cn China 19699 58

View Lastest Price from GSK-598809 L-tartrate sesquihydrate manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
GSK-598809 L-tartrate sesquihydrate pictures 2024-10-28 GSK-598809 L-tartrate sesquihydrate
1008521-09-2
US $2500.00-1520.00 / mg 10g TargetMol Chemicals Inc.
GSK-598809 L-tartrate sesquihydrate 3-Azabicyclo[3.1.0]hexane, 1-[2-fluoro-4-(trifluoromethyl)phenyl]-3-[3-[[4-methyl-5-(4-methyl-5-oxazolyl)-4H-1,2,4-triazol-3-yl]thio]propyl]-, (1S,5R)-, (2R,3R)-2,3-dihydroxybutanedioate, hydrate (2:2:3) 1008521-09-2
This site uses cookies
This website uses cookies and similar technologies to store and retrieve information about your use of this website. This information helps us to provide, analyse and improve our services, which may include personalised content or advertising. We may share this information with Google and other third parties. This cookies are necessary for our website to work properly . By clicking "Continue" or continuing to browse our site you are agreeing to our and our partners use of cookies.
Accept